Infammation induced-endothelial cells release angiogenesis associated-microRNAs into circulation by microparticles

Chinese Medical Journal

Volumn 127, Issue 12, 2014, Pages 2212-2217

  Zhang, Jing ^a   Ren, Jing Yi ^a   Chen, Hong ^a   Geng, Qiang ^a  

^a PEKING UNIVERSITY PEOPLE S HOSPITAL   (China)

Author keywords

Atherosclerosis; Inflammation; Microparticle; MicroRNAs

Indexed keywords

LIPOCORTIN 5; MICRORNA; TUMOR NECROSIS FACTOR ALPHA;

ANGIOGENESIS; ARTICLE; ATHEROSCLEROTIC PLAQUE; CELL CULTURE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIAL MICROPARTICLE; FLOW CYTOMETRY; HUMAN; HUMAN TISSUE; INFLAMMATORY DISEASE; PHENOTYPE; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REAL TIME POLYMERASE CHAIN REACTION; RNA EXTRACTION; TRANSMISSION ELECTRON MICROSCOPY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR TISSUE; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; INFLAMMATION; MEMBRANE MICROPARTICLE; METABOLISM;

ANNEXIN A5; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; GENE EXPRESSION REGULATION; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; INFLAMMATION; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902438914     PISSN: 03666999     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.0366-6999.20133228     Document Type: Article

References (23)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
2. Small EM, Olson EN. Pervasive roles of microRNAs in cardiovascular biology. Nature 2011; 469: 336-342.
3. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova Agadjanyan EL, et al. Circulating microRNAs as stable blood based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-10518.
4. Ren J, Zhang J, Xu N, Han G, Geng Q, Song J, et al. Signature of circulating microRNAs as potential biomarkers in vulnerable coronary artery disease. PLoS One 2013; 8: e80738.
5. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, et al. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: e3694.
6. Fichtlscherer S, Zeiher AM, Dimmeler S. Circulating microRNAs: biomarkers or mediators of cardiovascular diseases? Arterioscler Thromb Vasc Biol 2011; 31: 2383-2390.
7. Rautou PE, Leroyer AS, Ramkhelawon B, Devue C, Duflaut D, Vion AC, et al. microparticles from human atherosclerotic plaques promote endothelial ICAM 1 dependent monocyte adhesion and transendothelial migration. Circ Res 2011; 108: 335-343.
8. Ikuta S, Kirby JA, Shenton BK, Givan AL, Lennard TW. Human endothelial cells: effect of TNF alpha on peripheral blood mononuclear cell adhesion. Immunology 1991; 73: 71-76.
9. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med 1999; 340: 115-126.
10. Fichtlscherer S, De Rosa S, Fox H, Schwietz T, Fischer A, Liebetrau C, et al. Circulating microRNAs in patients with coronary artery disease. Circ Res 2010; 107: 677-684.
11. Weber DG, Johnen G, Bryk O, Jöckel KH, Brüning T. Identification of microRNA 103 in the cellular fraction of human peripheral blood as a potential biomarker for malignant mesothelioma a pilot study. PLoS One 2012; 7: e30221.
12. Leroyer AS, Isobe H, Lesèche G, Castier Y, Wassef M, Mallat Z, et al. Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 2007; 49: 772-777.
13. Boulanger CM, Scoazec A, Ebrahimian T, Henry P, Mathieu E, Tedgui A, et al. Circulating microparticles from patients with myocardial infarction cause endothelial dysfunction. Circulation 2001; 104: 2649-2652.
14. Bernal Mizrachi L, Jy W, Jimenez JJ, Pastor J, Mauro LM, Horstman LL, et al. High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 2003; 145: 962-970.
15. Valadi H. Exosome mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
16. Zernecke A, Bidzhekov K, Noels H, Shagdarsuren E, Gan L, Denecke B, et al. Delivery of microRNA 126 by apoptotic bodies induces CXCL12 dependent vascular protection. Sci Signal 2009; 2: ra81.
17. Petrocca F, Vecchione A, Croce CM. Emerging role of miR-106b-25/miR-17-92 clusters in the control of transforming growth factor beta signaling. Cancer Res 2008; 68: 8191-8194.
18. Geng L, Chaudhuri A, Talmon G, Wisecarver JL, Wang J. TGF-Beta suppresses VEGFA mediated angiogenesis in colon cancer metastasis. PLoS One 2013; 8: e59918.
19. Bonauer A, Carmona G, Iwasaki M, Mione M, Koyanagi M, Fischer A, et al. MicroRNA 92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009; 324: 1710-1713.
20. Suárez Y, Sessa WC. MicroRNAs as novel regulators of angiogenesis. Circ Res 2009; 104: 442-454.
21. Haver VG, Slart RH, Zeebregts CJ, Peppelenbosch MP, Tio RA. Rupture of vulnerable atherosclerotic plaques: microRNAs conducting the orchestra? Trends Cardiovasc Med 2010; 20: 65-71.
22. Zhao Y, Xu Y, Luo F, Xu W, Wang B, Pang Y, et al. Angiogenesis, mediated by microRNA 21, is involved arsenite induced carcinogenesis. Toxicol Lett 2013; 223: 35-41.
23. Liu LZ, Li C, Chen Q, Jing Y, Carpenter R, Jiang Y, et al. MiR 21 induced angiogenesis through AKT and ERK activation and HIF 1α expression. PLoS One 2011; 6: e19139.